Olympus Corporation (Olympus – Director, Representative Executive Officer, President and CEO: Yasuo Takeuchi) has been selected for inclusion in the 2021 Dow Jones Sustainability World Index (DJSI World) and the 2021 Dow Jones Sustainability Asia Pacific Index (DJSI Asia Pac … Read More »

Emmes today announced that it conducted the data and statistical analysis for the third iteration of the Adaptive COVID-19 Treatment Trial (ACTT-3), using its proprietary Advantage eClinical system.  The ACTT-3 trial assessed the efficacy and safety of interferon beta-1a plu … Read More »

Summary • Sotrovimab, developed with Vir, tested in lab and on hamsters • Key Omicron mutations did not elude drug activity in study • Tests continuing on further mutations Dec 2 (Reuters) – Laboratory analysis of the antibody-based COVID-19 therapy GlaxoSmithKline (GSK.L) ( … Read More »

A $1.6 billion biobucks pact sounds like a whopping number. But for Dyno Therapeutics, the deal with Astellas Pharma is the latest in a string of partnerships for its gene therapy vectors platform. Astellas is dishing out $18 million upfront and up to $1.6 billion in milesto … Read More »

 Exclusive deal for cutting-edge RNA technology in drug discovery and vaccines Australian clinical-stage drug development company Noxopharm (ASX:NOX) has in-licensed novel RNA technology developed by Hudson Institute of Medical Research. The exclusive global contract aims to … Read More »

Asian, Hispanic and Latino, Native Americans and Alaskan natives, Native Hawaiians and Pacific Islander, underrepresented in trials over the past decade Phesi Inc., a data-driven provider of AI-powered clinical development analytics products and solutions, has analyzed proto … Read More »

However, doctors show less agreement on impact on outcomes, with 53% saying apps provide better health outcomes, 47% that apps are highly effective in managing T2D December 01, 2021 09:00 AM Eastern Standard Time WATERTOWN, Mass.–(BUSINESS WIRE)–As the holidays add opportu … Read More »

Shanghai, 1st December 2021: WuXi STA – a subsidiary of WuXi AppTec– and Coherent Biopharma, announced the signing of a strategic partnership agreement. According to the agreement, WuXi STA will become the preferred CDMO partner and provide Coherent Biopharma with integrated … Read More »

SAN FRANCISCO, November 30, 2021—Curebase, a company committed to democratizing access to clinical studies, today announced that a newly released telemedicine feature of its decentralized clinical trial (DCT) platform has expanded patient access for its client Edesa Biotech, … Read More »

The Tecfidera patent loss is especially painful for Biogen in the wake of Aduhelm’s rocky launch. Despite Biogen’s best efforts, Tecfidera generics are here to stay, it seems. A U.S. appeals court has declined to resurrect a key patent on Biogen’s once-stalwart multiple scle … Read More »

Luer Adapter Fixation equalizes any difference in radii between syringe body and Luer adapter, while also offering extra space for product information. Blauvelt, NY, November 30, 2021 – Schreiner MediPharm, a Germany-based global provider of innovative functional label solut … Read More »

Despite advisers’ overall recommendation, they questioned the drug’s safety profile and urged some limits on its use. Merck & Co.’s experimental COVID-19 pill could be headed toward an emergency Food and Drug Administration clearance after a panel of outside experts vote … Read More »

Agreement strengthens NovAliX’s industrial and technological foothold within drug discovery sector Strasbourg, France, November 30, 2021 — NovAliX, a Contract Research Organization (CRO) specializing in drug research and development, today announces its partnership with Sano … Read More »

Funds will be used to develop EverImmune’s pipeline, harnessing gut microbiota in unique diagnostic and therapeutic approach; aimed at restoring response to anticancer immunotherapies  Villejuif, near Paris, France, November 30, 2021 – EverImmune, a biotechnology company spe … Read More »

Today, Vizgen (a life science company that specializes in single-cell spatial genomics) announced that it has assembled a Scientific and Technical Advisory Board (SAB) to support the company’s vision to bring the most advanced spatial-omics tools to the life science research … Read More »

Rouen, France, November 30, 2021 – Robocath, a company that designs, develops and commercializes innovative robotic platforms for the treatment of vascular diseases, today announces the successful completion of the first coronary angioplasty in China assisted by its R-One … Read More »

Following GMP certification earned in 2019 for its new production unit, Provepharm now has full control over its production chain for Europe and the US Marseille, France, November 29, 2021 – Provepharm Life Solutions, a French private pharmaceutical company that finds new ap … Read More »

CPhI awards the first ever CPhI Verified certificate to Medinfar – an international pharmaceutical manufacturer of Rx, cosmetics, food supplements and veterinary products. The new certification was given after a detailed evaluation by SGS – the world’s leading verification, … Read More »

— Adds LNG-451, a highly selective brain-penetrant precision therapy targeting EGFR exon 20 insertion mutations, to Blueprint Medicines’ lung cancer pipeline — Lengo Therapeutics on track to submit IND to FDA for LNG-451 by the end of 2021 — Lengo Therapeutics to be acqui … Read More »

In October, Vertex Pharmaceuticals announced stunning results in a type 1 diabetes patient who had been dosed with the company’s experimental fully differentiated pancreatic islet cell replacement therapy. After an infusion of VX-880, the patient began to produce his own ins … Read More »